BCL-XL apoptotic protein --- a drug target in lymphoma. More info coming soon.
Together with project 17801 this is also testing new methodology --- adaptive sampling. This is the standard sampling version of the system.
List of Contributors
This project is managed by Rafal Wiewiora at Memorial Sloan Kettering Cancer Center.
Graduate Student at Chodera Lab, Memorial Sloan Kettering Cancer Center, New York.
Interested in studying conformational dynamics of proteins using Molecular Dynamics and experimental methods, to make rational drug design better, cheaper and faster. Working with histone methyltransferases - a family of epigenetic regulators implicated in many cancers, aging and drug addiction.
Enter the project number: